HEADER LYASE 02-MAY-06 2GVD TITLE COMPLEX OF GS- WITH THE CATALYTIC DOMAINS OF MAMMALIAN ADENYLYL TITLE 2 CYCLASE: COMPLEX WITH TNP-ATP AND MN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADENYLATE CYCLASE TYPE 5; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C1A DOMAIN, RESIDUES 440-657; COMPND 5 SYNONYM: ADENYLATE CYCLASE TYPE V, ATP PYROPHOSPHATE-LYASE 5, COMPND 6 ADENYLYL CYCLASE 5, CA2+, -INHIBITABLE ADENYLYL CYCLASE; COMPND 7 EC: 4.6.1.1; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ADENYLATE CYCLASE TYPE 2; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: C2A DOMAIN, RESIDUES 870-1081; COMPND 13 SYNONYM: ADENYLATE CYCLASE TYPE II, ATP PYROPHOSPHATE-LYASE 2, COMPND 14 ADENYLYL CYCLASE 2; COMPND 15 EC: 4.6.1.1; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), ALPHA SUBUNIT; COMPND 19 CHAIN: C; COMPND 20 SYNONYM: ADENYLATE CYCLASE-STIMULATING G ALPHA PROTEIN; COMPND 21 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANIS LUPUS FAMILIARIS; SOURCE 3 ORGANISM_COMMON: DOG; SOURCE 4 ORGANISM_TAXID: 9615; SOURCE 5 STRAIN: FAMILIARIS; SOURCE 6 GENE: ADCY5; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PQE60-H6-VC1(580); SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 14 ORGANISM_COMMON: NORWAY RAT; SOURCE 15 ORGANISM_TAXID: 10116; SOURCE 16 GENE: ADCY2; SOURCE 17 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 19 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 20 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 21 EXPRESSION_SYSTEM_PLASMID: PQE60-IIC2; SOURCE 22 MOL_ID: 3; SOURCE 23 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 24 ORGANISM_COMMON: CATTLE; SOURCE 25 ORGANISM_TAXID: 9913; SOURCE 26 GENE: GNAS, GNAS1; SOURCE 27 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 28 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 29 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 30 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 31 EXPRESSION_SYSTEM_PLASMID: PQE60-H6-G(S)ALPHA KEYWDS ADENYLYL CYCLASE, GSA, TNP-ATP, LYASE EXPDTA X-RAY DIFFRACTION AUTHOR T.-C.MOU,S.R.SPRANG REVDAT 8 30-AUG-23 2GVD 1 REMARK REVDAT 7 20-OCT-21 2GVD 1 REMARK SEQADV LINK REVDAT 6 31-JAN-18 2GVD 1 REMARK REVDAT 5 23-SEP-15 2GVD 1 REMARK REVDAT 4 16-NOV-11 2GVD 1 VERSN HETATM REVDAT 3 24-FEB-09 2GVD 1 VERSN REVDAT 2 05-SEP-06 2GVD 1 JRNL REVDAT 1 04-JUL-06 2GVD 0 JRNL AUTH T.-C.MOU,A.GILLE,S.SURYANARAYANA,M.RICHTER,R.SEIFERT, JRNL AUTH 2 S.R.SPRANG JRNL TITL BROAD SPECIFICITY OF MAMMALIAN ADENYLYL CYCLASE FOR JRNL TITL 2 INTERACTION WITH 2',3'-SUBSTITUTED PURINE- AND PYRIMIDINE JRNL TITL 3 NUCLEOTIDE INHIBITORS. JRNL REF MOL.PHARMACOL. V. 70 878 2006 JRNL REFN ISSN 0026-895X JRNL PMID 16766715 JRNL DOI 10.1124/MOL.106.026427 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 264961.370 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 82.5 REMARK 3 NUMBER OF REFLECTIONS : 18842 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.245 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 925 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.08 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 65.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2568 REMARK 3 BIN R VALUE (WORKING SET) : 0.4120 REMARK 3 BIN FREE R VALUE : 0.4040 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 142 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.034 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5586 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 121 REMARK 3 SOLVENT ATOMS : 51 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -9.36000 REMARK 3 B22 (A**2) : -18.07000 REMARK 3 B33 (A**2) : 27.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM SIGMAA (A) : 0.87 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.50 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.82 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.570 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.070 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.600 ; 3.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.240 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.130 ; 4.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.30 REMARK 3 BSOL : 16.39 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : FKP.PARAM REMARK 3 PARAMETER FILE 3 : GSP.PARAM REMARK 3 PARAMETER FILE 4 : 128.PARAM REMARK 3 PARAMETER FILE 5 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : FKP.TOP REMARK 3 TOPOLOGY FILE 3 : GSP.TOP REMARK 3 TOPOLOGY FILE 4 : 128.TOP REMARK 3 TOPOLOGY FILE 5 : WATER.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2GVD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-MAY-06. REMARK 100 THE DEPOSITION ID IS D_1000037593. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-OCT-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0781 REMARK 200 MONOCHROMATOR : SI111 REMARK 200 OPTICS : KOHZU: DOUBLE CRYSTAL SI(111) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22450 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1TL7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 7.5-7.8% PEG8000, 0.5M NACL, 0.1M REMARK 280 PHOSPHATE BUFFER, PH 5.6, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 59.10000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 66.70000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 59.10000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 66.70000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH C 402 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 356 REMARK 465 HIS A 357 REMARK 465 HIS A 358 REMARK 465 HIS A 359 REMARK 465 HIS A 360 REMARK 465 HIS A 361 REMARK 465 HIS A 362 REMARK 465 ALA A 363 REMARK 465 MET A 364 REMARK 465 GLU A 365 REMARK 465 MET A 366 REMARK 465 LYS A 367 REMARK 465 ALA A 368 REMARK 465 ASP A 369 REMARK 465 ILE A 370 REMARK 465 ASN A 371 REMARK 465 ALA A 372 REMARK 465 LYS A 373 REMARK 465 GLN A 374 REMARK 465 GLU A 375 REMARK 465 ARG A 566 REMARK 465 CYS A 567 REMARK 465 THR A 568 REMARK 465 GLN A 569 REMARK 465 LYS A 570 REMARK 465 ARG A 571 REMARK 465 LYS A 572 REMARK 465 GLU A 573 REMARK 465 GLU A 574 REMARK 465 LYS A 575 REMARK 465 ALA A 576 REMARK 465 MET A 577 REMARK 465 ILE A 578 REMARK 465 ALA A 579 REMARK 465 LYS A 580 REMARK 465 ARG B 870 REMARK 465 SER B 871 REMARK 465 LEU B 872 REMARK 465 LYS B 873 REMARK 465 ASN B 874 REMARK 465 GLU B 875 REMARK 465 GLU B 876 REMARK 465 LEU B 877 REMARK 465 TYR B 878 REMARK 465 PRO B 954 REMARK 465 SER B 955 REMARK 465 GLN B 956 REMARK 465 GLU B 957 REMARK 465 HIS B 958 REMARK 465 ALA B 959 REMARK 465 GLN B 960 REMARK 465 GLU B 961 REMARK 465 PRO B 962 REMARK 465 GLU B 963 REMARK 465 GLU B 1078 REMARK 465 MET B 1079 REMARK 465 SER B 1080 REMARK 465 ARG B 1081 REMARK 465 MET C 1 REMARK 465 GLY C 2 REMARK 465 CYS C 3 REMARK 465 LEU C 4 REMARK 465 GLY C 5 REMARK 465 ASN C 6 REMARK 465 SER C 7 REMARK 465 LYS C 8 REMARK 465 THR C 9 REMARK 465 GLU C 10 REMARK 465 ASP C 11 REMARK 465 GLN C 12 REMARK 465 ARG C 13 REMARK 465 ASN C 14 REMARK 465 GLU C 15 REMARK 465 GLU C 16 REMARK 465 LYS C 17 REMARK 465 ALA C 18 REMARK 465 GLN C 19 REMARK 465 ARG C 20 REMARK 465 GLU C 21 REMARK 465 ALA C 22 REMARK 465 ASN C 23 REMARK 465 LYS C 24 REMARK 465 LYS C 25 REMARK 465 ILE C 26 REMARK 465 GLU C 27 REMARK 465 LYS C 28 REMARK 465 GLN C 29 REMARK 465 LEU C 30 REMARK 465 GLN C 31 REMARK 465 LYS C 32 REMARK 465 ASP C 33 REMARK 465 LYS C 34 REMARK 465 GLN C 35 REMARK 465 VAL C 36 REMARK 465 TYR C 37 REMARK 465 ARG C 38 REMARK 465 ASN C 66 REMARK 465 GLY C 67 REMARK 465 PHE C 68 REMARK 465 ASN C 69 REMARK 465 GLY C 70 REMARK 465 GLU C 71 REMARK 465 GLY C 72 REMARK 465 GLY C 73 REMARK 465 GLU C 74 REMARK 465 GLU C 75 REMARK 465 ASP C 76 REMARK 465 PRO C 77 REMARK 465 GLN C 78 REMARK 465 ALA C 79 REMARK 465 ALA C 80 REMARK 465 ARG C 81 REMARK 465 SER C 82 REMARK 465 ASN C 83 REMARK 465 SER C 84 REMARK 465 ASP C 85 REMARK 465 GLY C 86 REMARK 465 GLU C 87 REMARK 465 ILE C 383 REMARK 465 GLN C 384 REMARK 465 ARG C 385 REMARK 465 MET C 386 REMARK 465 HIS C 387 REMARK 465 LEU C 388 REMARK 465 ARG C 389 REMARK 465 GLN C 390 REMARK 465 TYR C 391 REMARK 465 GLU C 392 REMARK 465 LEU C 393 REMARK 465 LEU C 394 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 377 -111.00 -71.43 REMARK 500 MET A 378 -77.21 -5.38 REMARK 500 ILE A 435 -69.06 -97.52 REMARK 500 GLU A 468 -9.78 -59.45 REMARK 500 PHE A 504 107.09 -48.78 REMARK 500 SER A 508 148.40 175.87 REMARK 500 GLU B 907 55.90 73.58 REMARK 500 LYS B 938 -176.97 -170.64 REMARK 500 ALA B 952 168.44 171.64 REMARK 500 PHE B 991 10.65 81.85 REMARK 500 GLN B1013 -75.09 -45.86 REMARK 500 ALA C 89 -37.56 -37.10 REMARK 500 GLU C 101 -3.18 -59.66 REMARK 500 ALA C 102 -66.14 -93.76 REMARK 500 GLN C 236 3.98 -64.31 REMARK 500 GLN C 262 -12.86 -150.00 REMARK 500 LEU C 282 28.84 -142.31 REMARK 500 SER C 306 59.86 -113.94 REMARK 500 THR C 325 76.93 -119.24 REMARK 500 SER C 352 -158.97 -150.26 REMARK 500 ARG C 374 -71.80 -66.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A 582 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 396 OD2 REMARK 620 2 ASP A 396 OD1 50.4 REMARK 620 3 ILE A 397 O 101.1 121.7 REMARK 620 4 ASP A 440 OD2 67.1 113.5 87.5 REMARK 620 5 128 A 584 O2B 145.4 153.9 80.5 78.6 REMARK 620 6 128 A 584 O3B 158.8 109.2 84.4 134.0 55.4 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN C 396 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER C 54 OG REMARK 620 2 THR C 204 OG1 73.2 REMARK 620 3 GSP C 395 O2B 97.5 163.9 REMARK 620 4 GSP C 395 O2G 153.2 96.4 86.2 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN C 396 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL C 397 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN A 581 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN A 582 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSP C 395 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FKP A 583 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 128 A 584 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1TL7 RELATED DB: PDB REMARK 900 COMPLEX OF GS- WITH THE CATALYTIC DOMAINS OF MAMMALIAN ADENYLYL REMARK 900 CYCLASE: COMPLEX WITH 2'(3')-O-(N-METHYLANTHRANILOYL)-GUANOSINE 5'- REMARK 900 TRIPHOSPHATE AND MN REMARK 900 RELATED ID: 1U0H RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR THE INHIBITION OF MAMMALIAN ADENYLYL CYCLASE REMARK 900 BY MANT-GTP DBREF 2GVD A 363 580 UNP P30803 ADCY5_CANFA 444 661 DBREF 2GVD B 870 1081 UNP P26769 ADCY2_RAT 870 1081 DBREF 2GVD C 1 394 UNP P04896 GNAS_BOVIN 1 394 SEQADV 2GVD MET A 476 UNP P30803 VAL 557 ENGINEERED MUTATION SEQADV 2GVD MET A 356 UNP P30803 INITIATING METHIONINE SEQADV 2GVD HIS A 357 UNP P30803 EXPRESSION TAG SEQADV 2GVD HIS A 358 UNP P30803 EXPRESSION TAG SEQADV 2GVD HIS A 359 UNP P30803 EXPRESSION TAG SEQADV 2GVD HIS A 360 UNP P30803 EXPRESSION TAG SEQADV 2GVD HIS A 361 UNP P30803 EXPRESSION TAG SEQADV 2GVD HIS A 362 UNP P30803 EXPRESSION TAG SEQRES 1 A 225 MET HIS HIS HIS HIS HIS HIS ALA MET GLU MET LYS ALA SEQRES 2 A 225 ASP ILE ASN ALA LYS GLN GLU ASP MET MET PHE HIS LYS SEQRES 3 A 225 ILE TYR ILE GLN LYS HIS ASP ASN VAL SER ILE LEU PHE SEQRES 4 A 225 ALA ASP ILE GLU GLY PHE THR SER LEU ALA SER GLN CYS SEQRES 5 A 225 THR ALA GLN GLU LEU VAL MET THR LEU ASN GLU LEU PHE SEQRES 6 A 225 ALA ARG PHE ASP LYS LEU ALA ALA GLU ASN HIS CYS LEU SEQRES 7 A 225 ARG ILE LYS ILE LEU GLY ASP CYS TYR TYR CYS VAL SER SEQRES 8 A 225 GLY LEU PRO GLU ALA ARG ALA ASP HIS ALA HIS CYS CYS SEQRES 9 A 225 VAL GLU MET GLY MET ASP MET ILE GLU ALA ILE SER LEU SEQRES 10 A 225 VAL ARG GLU MET THR GLY VAL ASN VAL ASN MET ARG VAL SEQRES 11 A 225 GLY ILE HIS SER GLY ARG VAL HIS CYS GLY VAL LEU GLY SEQRES 12 A 225 LEU ARG LYS TRP GLN PHE ASP VAL TRP SER ASN ASP VAL SEQRES 13 A 225 THR LEU ALA ASN HIS MET GLU ALA GLY GLY LYS ALA GLY SEQRES 14 A 225 ARG ILE HIS ILE THR LYS ALA THR LEU SER TYR LEU ASN SEQRES 15 A 225 GLY ASP TYR GLU VAL GLU PRO GLY CYS GLY GLY GLU ARG SEQRES 16 A 225 ASN ALA TYR LEU LYS GLU HIS SER ILE GLU THR PHE LEU SEQRES 17 A 225 ILE LEU ARG CYS THR GLN LYS ARG LYS GLU GLU LYS ALA SEQRES 18 A 225 MET ILE ALA LYS SEQRES 1 B 212 ARG SER LEU LYS ASN GLU GLU LEU TYR HIS GLN SER TYR SEQRES 2 B 212 ASP CYS VAL CYS VAL MET PHE ALA SER ILE PRO ASP PHE SEQRES 3 B 212 LYS GLU PHE TYR THR GLU SER ASP VAL ASN LYS GLU GLY SEQRES 4 B 212 LEU GLU CYS LEU ARG LEU LEU ASN GLU ILE ILE ALA ASP SEQRES 5 B 212 PHE ASP ASP LEU LEU SER LYS PRO LYS PHE SER GLY VAL SEQRES 6 B 212 GLU LYS ILE LYS THR ILE GLY SER THR TYR MET ALA ALA SEQRES 7 B 212 THR GLY LEU SER ALA ILE PRO SER GLN GLU HIS ALA GLN SEQRES 8 B 212 GLU PRO GLU ARG GLN TYR MET HIS ILE GLY THR MET VAL SEQRES 9 B 212 GLU PHE ALA TYR ALA LEU VAL GLY LYS LEU ASP ALA ILE SEQRES 10 B 212 ASN LYS HIS SER PHE ASN ASP PHE LYS LEU ARG VAL GLY SEQRES 11 B 212 ILE ASN HIS GLY PRO VAL ILE ALA GLY VAL ILE GLY ALA SEQRES 12 B 212 GLN LYS PRO GLN TYR ASP ILE TRP GLY ASN THR VAL ASN SEQRES 13 B 212 VAL ALA SER ARG MET ASP SER THR GLY VAL LEU ASP LYS SEQRES 14 B 212 ILE GLN VAL THR GLU GLU THR SER LEU ILE LEU GLN THR SEQRES 15 B 212 LEU GLY TYR THR CYS THR CYS ARG GLY ILE ILE ASN VAL SEQRES 16 B 212 LYS GLY LYS GLY ASP LEU LYS THR TYR PHE VAL ASN THR SEQRES 17 B 212 GLU MET SER ARG SEQRES 1 C 394 MET GLY CYS LEU GLY ASN SER LYS THR GLU ASP GLN ARG SEQRES 2 C 394 ASN GLU GLU LYS ALA GLN ARG GLU ALA ASN LYS LYS ILE SEQRES 3 C 394 GLU LYS GLN LEU GLN LYS ASP LYS GLN VAL TYR ARG ALA SEQRES 4 C 394 THR HIS ARG LEU LEU LEU LEU GLY ALA GLY GLU SER GLY SEQRES 5 C 394 LYS SER THR ILE VAL LYS GLN MET ARG ILE LEU HIS VAL SEQRES 6 C 394 ASN GLY PHE ASN GLY GLU GLY GLY GLU GLU ASP PRO GLN SEQRES 7 C 394 ALA ALA ARG SER ASN SER ASP GLY GLU LYS ALA THR LYS SEQRES 8 C 394 VAL GLN ASP ILE LYS ASN ASN LEU LYS GLU ALA ILE GLU SEQRES 9 C 394 THR ILE VAL ALA ALA MET SER ASN LEU VAL PRO PRO VAL SEQRES 10 C 394 GLU LEU ALA ASN PRO GLU ASN GLN PHE ARG VAL ASP TYR SEQRES 11 C 394 ILE LEU SER VAL MET ASN VAL PRO ASP PHE ASP PHE PRO SEQRES 12 C 394 PRO GLU PHE TYR GLU HIS ALA LYS ALA LEU TRP GLU ASP SEQRES 13 C 394 GLU GLY VAL ARG ALA CYS TYR GLU ARG SER ASN GLU TYR SEQRES 14 C 394 GLN LEU ILE ASP CYS ALA GLN TYR PHE LEU ASP LYS ILE SEQRES 15 C 394 ASP VAL ILE LYS GLN ASP ASP TYR VAL PRO SER ASP GLN SEQRES 16 C 394 ASP LEU LEU ARG CYS ARG VAL LEU THR SER GLY ILE PHE SEQRES 17 C 394 GLU THR LYS PHE GLN VAL ASP LYS VAL ASN PHE HIS MET SEQRES 18 C 394 PHE ASP VAL GLY GLY GLN ARG ASP GLU ARG ARG LYS TRP SEQRES 19 C 394 ILE GLN CYS PHE ASN ASP VAL THR ALA ILE ILE PHE VAL SEQRES 20 C 394 VAL ALA SER SER SER TYR ASN MET VAL ILE ARG GLU ASP SEQRES 21 C 394 ASN GLN THR ASN ARG LEU GLN GLU ALA LEU ASN LEU PHE SEQRES 22 C 394 LYS SER ILE TRP ASN ASN ARG TRP LEU ARG THR ILE SER SEQRES 23 C 394 VAL ILE LEU PHE LEU ASN LYS GLN ASP LEU LEU ALA GLU SEQRES 24 C 394 LYS VAL LEU ALA GLY LYS SER LYS ILE GLU ASP TYR PHE SEQRES 25 C 394 PRO GLU PHE ALA ARG TYR THR THR PRO GLU ASP ALA THR SEQRES 26 C 394 PRO GLU PRO GLY GLU ASP PRO ARG VAL THR ARG ALA LYS SEQRES 27 C 394 TYR PHE ILE ARG ASP GLU PHE LEU ARG ILE SER THR ALA SEQRES 28 C 394 SER GLY ASP GLY ARG HIS TYR CYS TYR PRO HIS PHE THR SEQRES 29 C 394 CYS ALA VAL ASP THR GLU ASN ILE ARG ARG VAL PHE ASN SEQRES 30 C 394 ASP CYS ARG ASP ILE ILE GLN ARG MET HIS LEU ARG GLN SEQRES 31 C 394 TYR GLU LEU LEU HET MN A 581 1 HET MN A 582 1 HET FKP A 583 39 HET 128 A 584 46 HET MN C 396 1 HET CL C 397 1 HET GSP C 395 32 HETNAM MN MANGANESE (II) ION HETNAM FKP METHYLPIPERAZINOFORSKOLIN HETNAM 128 SPIRO(2,4,6-TRINITROBENZENE[1,2A]-2O',3O'-METHYLENE- HETNAM 2 128 ADENINE-TRIPHOSPHATE HETNAM CL CHLORIDE ION HETNAM GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE FORMUL 4 MN 3(MN 2+) FORMUL 6 FKP C30 H50 N2 O7 FORMUL 7 128 C16 H17 N8 O19 P3 FORMUL 9 CL CL 1- FORMUL 10 GSP C10 H16 N5 O13 P3 S FORMUL 11 HOH *51(H2 O) HELIX 1 1 PHE A 400 SER A 405 1 6 HELIX 2 2 THR A 408 ASN A 430 1 23 HELIX 3 3 ASP A 454 THR A 477 1 24 HELIX 4 4 SER A 508 GLY A 520 1 13 HELIX 5 5 THR A 529 TYR A 535 1 7 HELIX 6 6 CYS A 546 ARG A 550 5 5 HELIX 7 7 ASN A 551 HIS A 557 1 7 HELIX 8 8 ASP B 894 TYR B 899 1 6 HELIX 9 9 GLY B 908 ASP B 924 1 17 HELIX 10 10 LYS B 928 SER B 932 5 5 HELIX 11 11 TYR B 966 PHE B 991 1 26 HELIX 12 12 GLY B 1021 THR B 1033 1 13 HELIX 13 13 GLU B 1043 LEU B 1052 1 10 HELIX 14 14 GLY C 52 HIS C 64 1 13 HELIX 15 15 LYS C 88 ALA C 109 1 22 HELIX 16 16 ASN C 121 GLU C 123 5 3 HELIX 17 17 ASN C 124 VAL C 134 1 11 HELIX 18 18 PRO C 143 ASP C 156 1 14 HELIX 19 19 ASP C 156 GLU C 164 1 9 HELIX 20 20 ARG C 165 TYR C 169 5 5 HELIX 21 21 CYS C 174 LYS C 181 1 8 HELIX 22 22 LYS C 181 LYS C 186 1 6 HELIX 23 23 SER C 193 CYS C 200 1 8 HELIX 24 24 ASP C 229 PHE C 238 5 10 HELIX 25 25 ASN C 264 ASN C 278 1 15 HELIX 26 26 LYS C 293 GLY C 304 1 12 HELIX 27 27 LYS C 307 TYR C 311 5 5 HELIX 28 28 PHE C 312 ARG C 317 5 6 HELIX 29 29 ASP C 331 ALA C 351 1 21 HELIX 30 30 ASP C 368 ASP C 381 1 14 SHEET 1 A 5 LEU A 433 LEU A 438 0 SHEET 2 A 5 CYS A 441 SER A 446 -1 O CYS A 441 N LEU A 438 SHEET 3 A 5 TYR A 383 ASP A 396 -1 N SER A 391 O SER A 446 SHEET 4 A 5 VAL A 485 VAL A 496 -1 O HIS A 488 N ILE A 392 SHEET 5 A 5 ASP A 505 TRP A 507 -1 O ASP A 505 N GLY A 495 SHEET 1 B 6 LEU A 433 LEU A 438 0 SHEET 2 B 6 CYS A 441 SER A 446 -1 O CYS A 441 N LEU A 438 SHEET 3 B 6 TYR A 383 ASP A 396 -1 N SER A 391 O SER A 446 SHEET 4 B 6 VAL A 485 VAL A 496 -1 O HIS A 488 N ILE A 392 SHEET 5 B 6 ILE A 526 ILE A 528 1 O HIS A 527 N ILE A 487 SHEET 6 B 6 PHE A 562 LEU A 563 -1 O PHE A 562 N ILE A 528 SHEET 1 C 7 VAL B 934 ILE B 940 0 SHEET 2 C 7 THR B 943 THR B 948 -1 O THR B 943 N ILE B 940 SHEET 3 C 7 VAL B 885 SER B 891 -1 N CYS B 886 O THR B 948 SHEET 4 C 7 ARG B 997 GLY B1003 -1 O GLY B1003 N VAL B 885 SHEET 5 C 7 LYS B1038 THR B1042 1 O GLN B1040 N VAL B 998 SHEET 6 C 7 GLY B1068 VAL B1075 -1 O TYR B1073 N VAL B1041 SHEET 7 C 7 CYS B1056 VAL B1064 -1 N ILE B1062 O LEU B1070 SHEET 1 D 2 ILE B1006 ILE B1010 0 SHEET 2 D 2 GLN B1016 TRP B1020 -1 O ASP B1018 N GLY B1008 SHEET 1 E 6 PHE C 208 THR C 210 0 SHEET 2 E 6 MET C 221 ASP C 223 -1 O ASP C 223 N PHE C 208 SHEET 3 E 6 LEU C 43 GLY C 47 1 N LEU C 45 O PHE C 222 SHEET 4 E 6 ALA C 243 VAL C 247 1 O ILE C 245 N LEU C 44 SHEET 5 E 6 VAL C 287 LEU C 291 1 O ILE C 288 N PHE C 246 SHEET 6 E 6 CYS C 359 PHE C 363 1 O TYR C 360 N LEU C 289 SSBOND 1 CYS A 432 CYS A 444 1555 1555 2.06 LINK OD2 ASP A 396 MN MN A 582 1555 1555 2.43 LINK OD1 ASP A 396 MN MN A 582 1555 1555 2.65 LINK O ILE A 397 MN MN A 582 1555 1555 2.44 LINK OD1 ASP A 440 MN MN A 581 1555 1555 2.36 LINK OD2 ASP A 440 MN MN A 582 1555 1555 2.19 LINK MN MN A 582 O2B 128 A 584 1555 1555 2.26 LINK MN MN A 582 O3B 128 A 584 1555 1555 2.55 LINK OG SER C 54 MN MN C 396 1555 1555 2.34 LINK OG1 THR C 204 MN MN C 396 1555 1555 2.33 LINK O2B GSP C 395 MN MN C 396 1555 1555 2.13 LINK O2G GSP C 395 MN MN C 396 1555 1555 2.27 CISPEP 1 LEU A 448 PRO A 449 0 -0.11 CISPEP 2 VAL C 114 PRO C 115 0 0.15 SITE 1 AC1 3 SER C 54 THR C 204 GSP C 395 SITE 1 AC2 3 ALA C 48 ALA C 249 ARG C 265 SITE 1 AC3 2 ASP A 396 ASP A 440 SITE 1 AC4 4 ASP A 396 ILE A 397 ASP A 440 128 A 584 SITE 1 AC5 21 GLU C 50 SER C 51 GLY C 52 LYS C 53 SITE 2 AC5 21 SER C 54 THR C 55 ASP C 173 LEU C 198 SITE 3 AC5 21 ARG C 199 CYS C 200 ARG C 201 THR C 204 SITE 4 AC5 21 GLY C 226 ASN C 292 LYS C 293 ASP C 295 SITE 5 AC5 21 LEU C 296 CYS C 365 ALA C 366 VAL C 367 SITE 6 AC5 21 MN C 396 SITE 1 AC6 13 CYS A 441 TYR A 443 ASP A 505 VAL A 506 SITE 2 AC6 13 TRP A 507 SER A 508 VAL A 511 THR A 512 SITE 3 AC6 13 ASN A 515 PHE B 895 LYS B 896 TYR B 899 SITE 4 AC6 13 SER B 942 SITE 1 AC7 18 HOH A 68 ILE A 397 GLY A 399 PHE A 400 SITE 2 AC7 18 ALA A 409 LEU A 412 VAL A 413 LEU A 416 SITE 3 AC7 18 GLY A 439 ASP A 440 ARG A 484 MN A 582 SITE 4 AC7 18 PHE B 889 TRP B1020 ASN B1022 ASN B1025 SITE 5 AC7 18 SER B1028 LYS B1065 CRYST1 118.200 133.400 70.600 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008460 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007496 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014164 0.00000